Alexis Gil II Sells 1,992 Shares of Integral Ad Science (NASDAQ:IAS) Stock

Integral Ad Science Holding Corp. (NASDAQ:IAS) CAO Alexis Gil II sold 1,992 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $10.18, for a total transaction of $20,278.56. Following the completion of the sale, the chief accounting officer directly owned 143,148 shares of the company’s stock, valued at approximately $1,457,246.64. This trade represents a 1.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Alexis Gil II also recently made the following trade(s):

• On Friday, October 3rd, Alexis Gil II sold 3,527 shares of Integral Ad Science stock. The stock was sold at an average price of $10.18, for a total transaction of $35,904.86.
• On Wednesday, September 24th, Alexis Gil II sold 25,901 shares of Integral Ad Science stock. The stock was sold at an average price of $10.18, for a total transaction of $263,672.18.

Integral Ad Science Stock Performance

NASDAQ:IAS opened at $10.19 on Wednesday. The company has a 50-day moving average of $8.97 and a 200-day moving average of $8.22. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of 29.97, a PEG ratio of 1.45 and a beta of 1.60. Integral Ad Science Holding Corp. has a 52 week low of $6.26 and a 52 week high of $13.62.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.03. The company had revenue of $149.20 million during the quarter, compared to the consensus estimate of $143.02 million. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Sell-side analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

Institutional Investors Weigh In On Integral Ad Science

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. American Century Companies Inc. acquired a new stake in Integral Ad Science in the 1st quarter valued at about $711,000. Delphi Management Inc. MA acquired a new stake in Integral Ad Science in the 2nd quarter valued at about $539,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Integral Ad Science by 42.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 155,010 shares of the company’s stock worth $1,618,000 after buying an additional 46,395 shares during the period. Envestnet Asset Management Inc. grew its position in shares of Integral Ad Science by 165.6% during the 1st quarter. Envestnet Asset Management Inc. now owns 84,471 shares of the company’s stock worth $681,000 after buying an additional 52,664 shares during the period. Finally, Bank of New York Mellon Corp grew its position in shares of Integral Ad Science by 15.9% during the 1st quarter. Bank of New York Mellon Corp now owns 291,079 shares of the company’s stock worth $2,346,000 after buying an additional 39,988 shares during the period. Institutional investors and hedge funds own 95.78% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on IAS. Wall Street Zen upgraded Integral Ad Science from a “hold” rating to a “buy” rating in a research report on Sunday, August 10th. Oppenheimer downgraded shares of Integral Ad Science from an “outperform” rating to a “market perform” rating in a report on Wednesday, September 24th. Barclays lifted their price target on shares of Integral Ad Science from $9.00 to $10.00 and gave the company an “equal weight” rating in a report on Friday, August 8th. Loop Capital downgraded shares of Integral Ad Science from a “buy” rating to a “hold” rating and set a $10.30 price target for the company. in a report on Wednesday, September 24th. Finally, BMO Capital Markets set a $10.30 price target on shares of Integral Ad Science and gave the company a “market perform” rating in a report on Wednesday, September 24th. One research analyst has rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Integral Ad Science presently has a consensus rating of “Hold” and an average price target of $12.81.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.